Arjen L. Sutterland

1.6k total citations · 1 hit paper
32 papers, 1.1k citations indexed

About

Arjen L. Sutterland is a scholar working on Biological Psychiatry, Psychiatry and Mental health and Parasitology. According to data from OpenAlex, Arjen L. Sutterland has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Biological Psychiatry, 8 papers in Psychiatry and Mental health and 7 papers in Parasitology. Recurrent topics in Arjen L. Sutterland's work include Tryptophan and brain disorders (12 papers), Toxoplasma gondii Research Studies (7 papers) and Schizophrenia research and treatment (7 papers). Arjen L. Sutterland is often cited by papers focused on Tryptophan and brain disorders (12 papers), Toxoplasma gondii Research Studies (7 papers) and Schizophrenia research and treatment (7 papers). Arjen L. Sutterland collaborates with scholars based in Netherlands, United States and France. Arjen L. Sutterland's co-authors include Lieuwe de Haan, Tom van Gool, Guillaume Fond, Marion Leboyer, Maarten W.J. Koeter, René Lutter, Robert H. Yolken, Andreı̈ Szöke, Lieuwe de Haan and Geeske van Rooijen and has published in prestigious journals such as Psychological Medicine, Journal of Affective Disorders and Schizophrenia Bulletin.

In The Last Decade

Arjen L. Sutterland

32 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta‐analysis

2015 320 citations Arjen L. Sutterland, Guillaume Fond et al. Acta Psychiatrica Scandinavica profile →

Peers

Countries citing papers authored by Arjen L. Sutterland

Since Specialization

Citations

This map shows the geographic impact of Arjen L. Sutterland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arjen L. Sutterland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arjen L. Sutterland more than expected).

Fields of papers citing papers by Arjen L. Sutterland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arjen L. Sutterland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arjen L. Sutterland. The network helps show where Arjen L. Sutterland may publish in the future.

Co-authorship network of co-authors of Arjen L. Sutterland

This figure shows the co-authorship network connecting the top 25 collaborators of Arjen L. Sutterland. A scholar is included among the top collaborators of Arjen L. Sutterland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arjen L. Sutterland. Arjen L. Sutterland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Skin advanced glycation end products, indicating cumulative oxidative stress, associated with schizophrenia but not with psychosis-like experiences 2025 ·Schizophrenia Research ·(unknown), (unknown), (unknown), (unknown), Arjen L. Sutterland, Jentien M. Vermeulen, Hanno L. Tan, (unknown)	1
2	The interplay between psychopathological symptoms: transdiagnostic cross-lagged panel network model 2022 ·BJPsych Open ·(unknown), Karin J. H. Verweij, Derek de Beurs, Claudi Bockting, Anja Lok, Arjen L. Sutterland, Geeske van Rooijen, Guido van Wingen, Damiaan Denys, Nienke Vulink, Dorien H. Nieman	16
3	Ethnic discrimination and depressed mood: The role of autonomic regulation 2021 ·Journal of Psychiatric Research ·(unknown), Arjen L. Sutterland, Didier Collard, (unknown), Mirjam van Zuiden, Jasper B. Zantvoord, Hanno L. Tan, Irene G. M. van Valkengoed, Bert‐Jan H. van den Born, Aeilko H. Zwinderman, Lieuwe de Haan, Anja Lok	1
4	The relationship between cognitive functioning and psychopathology in patients with psychiatric disorders: a transdiagnostic network analysis 2021 ·Psychological Medicine ·(unknown), Dorien H. Nieman, (unknown), Anja Lok, Roel J. T. Mocking, Pelle de Koning, Valeria V. Krzhizhanovskaya, Claudi Bockting, Geeske van Rooijen, Dirk J. A. Smit, Arjen L. Sutterland, Karin J. H. Verweij, Guido van Wingen, Johanna T. W. Wigman, Nienke Vulink, Damiaan Denys	36
5	Skin autofluorescence of advanced glycation end products and mortality in affective disorders in the lifelines cohort study: A mediation analysis 2021 ·Journal of Affective Disorders ·(unknown), Arjen L. Sutterland, (unknown), Frederike Schirmbeck, Danny M. Cohn, Anja Lok, Hanno L. Tan, Aeilko H. Zwinderman, Lieuwe de Haan	3
6	Resting-state brain oscillations predict cognitive function in psychiatric disorders: A transdiagnostic machine learning approach 2021 ·NeuroImage Clinical ·(unknown), (unknown), Sarah L. Master, Karin J. H. Verweij, Anja Lok, Arjen L. Sutterland, Nienke Vulink, Damiaan Denys, Dirk J. A. Smit, Dorien H. Nieman	23
7	Association between skin autofluorescence of advanced glycation end products and affective disorders in the lifelines cohort study 2020 ·Journal of Affective Disorders ·(unknown), Arjen L. Sutterland, (unknown), Frederike Schirmbeck, Danny M. Cohn, Anja Lok, Hanno L. Tan, Aeilko H. Zwinderman, Lieuwe de Haan	8
8	Protocol Across study: longitudinal transdiagnostic cognitive functioning, psychiatric symptoms, and biological parameters in patients with a psychiatric disorder 2020 ·BMC Psychiatry ·Dorien H. Nieman, (unknown), Nienke Vulink, Dirk J. A. Smit, Guido van Wingen, Pelle de Koning, Arjen L. Sutterland, Roel J. T. Mocking, Claudi Bockting, Karin J. H. Verweij, Anja Lok, Damiaan Denys	7
9	Skin autofluorescence of advanced glycation end products and course of affective disorders in the lifelines cohort study, a prospective investigation 2020 ·Journal of Affective Disorders ·(unknown), Arjen L. Sutterland, Frederike Schirmbeck, Danny M. Cohn, Anja Lok, Hanno L. Tan, Aeilko H. Zwinderman, Lieuwe de Haan	1
10	Association between Advanced Glycation End products and brain volumes in recent onset psychosis 2020 ·Schizophrenia Research ·(unknown), (unknown), Arjen L. Sutterland, Anouk Schrantee, Lieuwe de Haan	2
11	Altered peripheral blood compounds in drug-naïve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis 2020 ·Brain Behavior and Immunity ·Nuray Çakici, Arjen L. Sutterland, Brenda W.J.H. Penninx, Virgil A. S. H. Dalm, Lieuwe de Haan, Nico J.M. van Beveren	122
12	Effects of Toxoplasma gondii infection and schizophrenia comorbidity on serum lipid profile: A population retrospective study from Eastern China 2020 ·Microbial Pathogenesis ·Fei Xu, Xinyu Ma, Yuwei Zhu, Arjen L. Sutterland, (unknown), (unknown), (unknown), Liying Qiu, (unknown)	5
13	Driving us mad: the association of Toxoplasma gondii with suicide attempts and traffic accidents – a systematic review and meta-analysis 2019 ·Psychological Medicine ·Arjen L. Sutterland, (unknown), (unknown), Tom van Gool, Marion Leboyer, Guillaume Fond, Lieuwe de Haan	50
14	Efficacy, tolerability, and safety of low-dose and high-dose baclofen in the treatment of alcohol dependence: A systematic review and meta-analysis 2018 ·European Neuropsychopharmacology ·Mimi Pierce, Arjen L. Sutterland, Esther M. Beraha, Kirsten C. Morley, Wim van den Brink	80
15	Advanced Glycation End Products in Recent-Onset Psychosis Indicate Early Onset of Cardiovascular Risk 2017 ·The Journal of Clinical Psychiatry ·(unknown), Arjen L. Sutterland, Maarten W.J. Koeter, René Lutter, (unknown), Lieuwe de Haan	16
16	Toxoplasma gondii : applications thérapeutiques potentielles en psychiatrie 2016 ·L information psychiatrique ·Guillaume Fond, Arjen L. Sutterland	1
17	In vivo (R)-[11C]PK11195 PET imaging of 18kDa translocator protein in recent onset psychosis 2016 ·Schizophrenia ·Thalia F. van der Doef, Lot D. de Witte, Arjen L. Sutterland, (unknown), Maqsood Yaqub, Ronald Boellaard, Lieuwe de Haan, Jonas Eriksson, Adriaan A. Lammertsma, René S. Kahn, Bart N.M. van Berckel	53
18	Early-life metal exposure and schizophrenia: A proof-of-concept study using novel tooth-matrix biomarkers 2016 ·European Psychiatry ·(unknown), Eva Velthorst, Chris Gennings, Lieuwe de Haan, Christine Austin, Arjen L. Sutterland, Josephine Mollon, Sophia Frangou, Robert O. Wright, Manish Arora, Abraham Reichenberg	39
19	Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta‐analysis breakdown → 2015 ·Acta Psychiatrica Scandinavica ·Arjen L. Sutterland, Guillaume Fond, (unknown), Maarten W.J. Koeter, René Lutter, Tom van Gool, Robert H. Yolken, Andreı̈ Szöke, Marion Leboyer, Lieuwe de Haan	320
20	Annual incidence rate of schizophrenia and schizophrenia spectrum disorders in a longitudinal population-based cohort study 2013 ·Social Psychiatry and Psychiatric Epidemiology ·Arjen L. Sutterland, Jeanne P. Dieleman, Jitschak G. Storosum, (unknown), (unknown), (unknown), Damiaan Denys, Lieuwe de Haan, Miriam Sturkenboom	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact